Monthly Archives: January 2012
Lecture by stem cell researcher tomorrow
Celebrated adult stem cell researcher Shinya Yamanaka will deliver a lecture, ‘New era of medicine with iPS cells', here on Monday as part of a three-city lecture series. Prof. Yamanaka's scientific breakthrough was the creation of embryonic-like stem cells from adult skin cells. Continue reading
UCD stem cell research battles Huntington's disease
A team of researchers at UC Davis has pioneered a technique to use stem cells to smother the genetic problem that causes Huntington's disease. Continue reading
bboy force the stem cell miracle man saved from death rebuilt by stemcells PART 1 thanks U of M – Video
24-12-2011 12:34 Witness the miracle. The dancer you see flat-lined(heart totally stopped) due to a genetic circumstance at a young age recently and survived death only by a miracle Continue reading
Collaborative research sheds light on new cancer stem cell therapies
ScienceDaily (Jan. 27, 2012) — A collaborative anti-cancer research jointly conducted by The Hong Kong Polytechnic University (PolyU), Peking University Shenzhen Graduate School and Nevada Cancer Institute has led to the development of a novel class of chemical inhibitors that specifically target cancer cells with pluripotency. Continue reading
Seattle Genetics and Millennium Report Data from Phase I Trial of ADCETRIS™ in Front-line Mature T-Cell Lymphomas
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company today announced interim results from 32 patients treated to date in a phase I clinical trial of ADCETRIS administered in combination with or sequentially with chemotherapy for the treatment of newly diagnosed systemic anaplastic large cell lymphoma and other CD30-positive mature T-cell lymphoma patients. Continue reading
Genetic Mutation That Triggers Pancreatic Cancer Identified
Scientists at The University of Texas MD Anderson Cancer Center have identified a self-perpetuating “loop” of molecular activity that fuels pancreatic cancer by linking two signature characteristics of the disease – Kras, a gene that serves as a molecular on-off switch, but gets stuck on the “on” position when mutated, and NF-κB, a protein complex that controls activation of genes. In addition … Continue reading
Gazette.Net: Rockvilles Micromet agrees to $1.16B takeover by Amgen
In a show of faith in an experimental cancer treatment now in clinical trials, California biotech giant Amgen has agreed to acquire Rockville’s Micromet for $1.16 billion in cash. Continue reading
Pitt researchers make anti-aging breakthrough
It’s not the fountain of youth, but when it comes to anti-aging serums, Pitt researchers might… Continue reading
Grant will fund stem cell research internships
LONG BEACH – Developing healing therapies derived from stem cells—body cells that can grow into a variety of other tissues—is an increasing emphasis in modern healthcare research and businesses. Continue reading